Trial Profile
Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2018
Price :
$35
*
At a glance
- Drugs Loperamide (Primary)
- Indications Rectal cancer; Short bowel syndrome; Ulcerative colitis
- Focus Therapeutic Use
- 27 Jul 2018 New source identified and integrated (ClinicalTrials.gov NCT02266849).
- 27 Jul 2018 New trial record